These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25965606)

  • 21. Alternative stents in ST-segment elevation myocardial infarction: improving the efficacy of primary percutaneous coronary intervention.
    Yetgin T; Nakatani S; Onuma Y; van Geuns RJ
    Future Cardiol; 2015 May; 11(3):347-57. PubMed ID: 26021640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and effectiveness of the Genous™ endothelial progenitor cell-capture stent in the first year following ST-elevation acute myocardial infarction: A single center experience and review of the literature.
    Pereira-da-Silva T; Bernardes L; Cacela D; Fiarresga A; Sousa L; Patrício L; Ferreira RC
    Cardiovasc Revasc Med; 2013; 14(6):338-42. PubMed ID: 24216000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-ST-segment elevation myocardial infarction related to vulnerable neoatheroma in bare-metal stents 2 years after percutaneous coronary intervention of a coronary saphenous vein graft.
    Roleder T; Wańha W; Smolka G; Ochała A; Wojakowski W
    JACC Cardiovasc Interv; 2014 Aug; 7(8):e95-6. PubMed ID: 25086848
    [No Abstract]   [Full Text] [Related]  

  • 24. Frequency, mechanisms, and implications of late peri-stent contrast staining: analysis (from the HORIZONS-AMI Trial).
    Yakushiji T; Inaba S; Maehara A; Brener SJ; Witzenbichler B; Guagliumi G; Brodie BR; Kellett MA; Xu K; Mehran R; Mintz GS; Stone GW
    Am J Cardiol; 2013 Jun; 111(11):1587-92. PubMed ID: 23497778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of chronic total occlusion revascularization in patients with acute myocardial infarction treated by primary percutaneous coronary intervention.
    Valenti R; Marrani M; Cantini G; Migliorini A; Carrabba N; Vergara R; Cerisano G; Parodi G; Antoniucci D
    Am J Cardiol; 2014 Dec; 114(12):1794-800. PubMed ID: 25438904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late stent thrombosis of a second-generation drug- eluting stent.
    Karjalainen PP; Nammas W; Ylitalo A
    J Invasive Cardiol; 2012 Oct; 24(10):E225-7. PubMed ID: 23043049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex-related Impact on Clinical Outcome of Everolimus-eluting Versus Bare-metal Stents in ST-segment Myocardial Infarction. Insights From the EXAMINATION Trial.
    Regueiro A; Fernández-Rodríguez D; Brugaletta S; Martín-Yuste V; Masotti M; Freixa X; Cequier Á; Íñiguez A; Serruys PW; Sabaté M;
    Rev Esp Cardiol (Engl Ed); 2015 May; 68(5):382-9. PubMed ID: 25444377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Very late drug-eluting stent thrombosis and cardiogenic shock: 1,249 days after implantation.
    Chen JP
    J Invasive Cardiol; 2007 Dec; 19(12):E381-4. PubMed ID: 18180534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased rate of stent thrombosis and target lesion revascularization after filter protection in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: 15-month follow-up of the DEDICATION (Drug Elution and Distal Protection in ST Elevation Myocardial Infarction) trial.
    Kaltoft A; Kelbaek H; Kløvgaard L; Terkelsen CJ; Clemmensen P; Helqvist S; Lassen JF; Thuesen L
    J Am Coll Cardiol; 2010 Mar; 55(9):867-71. PubMed ID: 20185036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential 1-year clinical outcomes for ST-segment elevation myocardial infarction related to stent thrombosis or saphenous vein graft thrombosis.
    Arzamendi D; Ly HQ; Tanguay JF; Armero S; Jilaihawi H; Gallo R; Ibrahim R; L'Allier P; Blondeau L; Gosselin G; Gregoire J; Doucet S
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):193-200. PubMed ID: 21805615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.
    Tolerico PH; Cohen DJ; Kleiman NS; Berger PB; Brilakis ES; Piana RN; Shammo S; Keyes MJ; Kennedy KF; Massaro JM; Saucedo JF;
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1127-36. PubMed ID: 22431166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure.
    Harskamp RE; Beijk MA; Damman P; Kuijt WJ; Woudstra P; Grundeken MJ; Kloek JJ; Tijssen JG; de Mol BA; de Winter RJ
    J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):438-45. PubMed ID: 22828774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accidentally crushed stent during complex bifurcation treatment. A potential cause of very late stent thrombosis.
    Würtz M; Christiansen EH; Kristensen SD; Holm NR
    Int J Cardiol; 2015 Oct; 197():113-5. PubMed ID: 26142195
    [No Abstract]   [Full Text] [Related]  

  • 34. Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.
    Kereiakes DJ; Yeh RW; Massaro JM; Driscoll-Shempp P; Cutlip DE; Steg PG; Gershlick AH; Darius H; Meredith IT; Ormiston J; Tanguay JF; Windecker S; Garratt KN; Kandzari DE; Lee DP; Simon DI; Iancu AC; Trebacz J; Mauri L;
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1552-62. PubMed ID: 26493248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Comparison With Short-Term Follow-Up of Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Stent in Primary Percutaneous Coronary Interventions.
    Cortese B; Ielasi A; Romagnoli E; Varricchio A; Cuculo A; Loi B; Pisano F; Corrado D; Sesana M; La Vecchia L; Summaria F; Tespili M; Silva Orrego P; Tognoni G; Steffenino G
    Am J Cardiol; 2015 Sep; 116(5):705-10. PubMed ID: 26100584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum alkaline phosphatase is a predictor of mortality, myocardial infarction, or stent thrombosis after implantation of coronary drug-eluting stent.
    Park JB; Kang DY; Yang HM; Cho HJ; Park KW; Lee HY; Kang HJ; Koo BK; Kim HS
    Eur Heart J; 2013 Mar; 34(12):920-31. PubMed ID: 23242189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term results of the randomized comparison of everolimus-eluting stents and sirolimus-eluting stent in patients with ST elevation myocardial infarction (RACES-MI trial).
    Di Lorenzo E; Sauro R; Capasso M; Lanni F; Lanzillo T; Carbone G; Manganelli F; Palmieri V; Serino V; Pagliuca MR; Rosato G; Suryapranata H; De Luca G
    Int J Cardiol; 2016 Jan; 202():177-82. PubMed ID: 26397405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials.
    Cassese S; Byrne RA; Tada T; King LA; Kastrati A
    Eur Heart J; 2012 Dec; 33(24):3078-87. PubMed ID: 23091199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent in patients with acute myocardial infarction.
    Lee HJ; Park TK; Song YB; Choi YJ; Yu CW; Yang JH; Hahn JY; Choi SH; Choi RK; Choi JH; Park JS; Kim JS; Kim TH; Jang HJ; Lee SH; Shim WH; Roh YM; Gwon HC
    Int J Cardiol; 2015 Mar; 183():190-7. PubMed ID: 25668147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Closed versus open cell stent for high-risk percutaneous coronary interventions in ST-elevation acute myocardial infarction: the Closed versus Open Cells stent for High risk percutaneous coronary Interventions in ST-Elevation acute myocardial infarction (COCHISE) pilot study.
    Sciahbasi A; Pendenza G; Golino L; Romagnoli E; Caferri G; Patrizi R; Summaria F; Serra F; Giannico MB; Bruno E; Sommariva L; Lioy E
    Am Heart J; 2013 Mar; 165(3):415-20. PubMed ID: 23453112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.